TrialThe international journal of neuropsychopharmacology2026

Pharmacokinetic and pharmacodynamic results from a randomized controlled study with the growth hormone secretagogue receptor blocker PF-5190457 in recently abstinent patients with alcohol use disorder.

Ryan E Tyler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.